Status:
RECRUITING
A Single Center Randomized Controlled Study on the Promotion of Rapid Recovery
Lead Sponsor:
Zhe Meng
Conditions:
Nonfunctional Adrenal Cortex Adenoma
Primary Aldosteronism
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to exploring the role of tubeless after adrenalectomy surgery. The main questions it aims to answer are: 1. The safety of tubeless laparoscopic adrenalectomy； 2. Th...
Detailed Description
The design type of this study is a prospective single center randomized controlled study, with a plan to recruit 200 patients who underwent laparoscopic adrenalectomy for the study. The intervention m...
Eligibility Criteria
Inclusion Criteria:
- According to the 2022 edition of the Chinese Guidelines for Diagnosis and Treatment of Urological Diseases, patients who meet the surgical indications
- The patient has signed an informed consent form before joining the clinical trial, and the age at the time of signing the informed consent form is 18-70 years old.
Exclusion Criteria:
- Patients with complications that seriously affect treatment or quality of life
- The patient has any physical condition that the researcher believes will affect the clinical status
- Patients who have placed vascular stents such as heart and cerebrovascular stents within the past year
- Pregnant or lactating patients
Key Trial Info
Start Date :
January 3 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2027
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06250699
Start Date
January 3 2024
End Date
June 30 2027
Last Update
February 13 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zhongnan hospital
Wuhan, Hubei, China, 430071